Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

University of Alberta

$40,000.00

The role of respiratory complex assembly defects in development of agonist-induced mitochondrial dysfunction

EF 2011-12

Résumé
Lay title: Causes of mitochondrial dysfunction in disease. Mitochondria are little cells found within our cells. Mitochondria are very important. They make energy necessary for our cells to be healthy. In diseases such as cancer, neurodegenerative disorders and cardiovascular disease, mitochondrial function is decreased. We suffer from oxidative stress and a lack of energy. We think that mitochondrial function is affected in disease, at least in part, because our body makes an excess of certain hormones when we are sick. For instance, when we experience a cardiovascular disease called ""hypertension"" or high blood pressure, it is almost certain that we are producing an excess of the hormones angiotensin II (the target of the famous ""ACE inhibitors"") and catecholamines (the targets of the well known ""alpha and beta blockers""). We recently discovered that, in hypertension, some mitochondrial components are not properly assembled. Moreover, we have observed and published that acute (ie, short-term) exposure of cells to angiotensin II or catecholamine hormones causes oxidative stress and impairs mitochondrial respiration. In this research we will expand our current understanding of mitochondrial biology and mitochondrial regulation in health and disease. We will establish the mechanism by which mitochondrial dysfunction is induced by pro-hypertensive hormones such as angiotensin II and catecholamines. This research is important because we think that similar mechanisms operate in cancer and neurodenegerative conditions as well as in hypertension. Our research will be carried out by (and significantly contribute to the training of) 1 graduate student and 1 research technician.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
250267-2010
Name nom
FernandezPatron, Carlos
Department département
Biochemistry
Organization id
9
Institution établissement
University of Alberta
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2011
Competition year année de concours
2010
Award amount
40000
Program id
RGPIN
Program nane en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5403
Research subject group en
Biochemistry
Research subject group fr
Biochimie
Research subject en
Proteins and peptides, amino acids
Research subject fr
Protéines et peptides, acides aminés
Partie
2
Nb partie
5
Application title
The role of respiratory complex assembly defects in development of agonist-induced mitochondrial dysfunction
Keyword
NSERC
Application summary
Lay title: Causes of mitochondrial dysfunction in disease. Mitochondria are little cells found within our cells. Mitochondria are very important. They make energy necessary for our cells to be healthy. In diseases such as cancer, neurodegenerative disorders and cardiovascular disease, mitochondrial function is decreased. We suffer from oxidative stress and a lack of energy. We think that mitochondrial function is affected in disease, at least in part, because our body makes an excess of certain hormones when we are sick. For instance, when we experience a cardiovascular disease called ""hypertension"" or high blood pressure, it is almost certain that we are producing an excess of the hormones angiotensin II (the target of the famous ""ACE inhibitors"") and catecholamines (the targets of the well known ""alpha and beta blockers""). We recently discovered that, in hypertension, some mitochondrial components are not properly assembled. Moreover, we have observed and published that acute (ie, short-term) exposure of cells to angiotensin II or catecholamine hormones causes oxidative stress and impairs mitochondrial respiration. In this research we will expand our current understanding of mitochondrial biology and mitochondrial regulation in health and disease. We will establish the mechanism by which mitochondrial dysfunction is induced by pro-hypertensive hormones such as angiotensin II and catecholamines. This research is important because we think that similar mechanisms operate in cancer and neurodenegerative conditions as well as in hypertension. Our research will be carried out by (and significantly contribute to the training of) 1 graduate student and 1 research technician.